Flagship Pioneering Fund VII, L.P.

Insider profile

Flagship Pioneering Fund VII, L.P.'s trades of Syros Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-16 2024-12-27 PrS Proposed sale
79,897
85.35
US$64,809
79,897 85.35 US$64,809
2024-12-27 2024-12-27 PrS Proposed sale
55,648
392.60
US$1,819,944
55,648 392.60 US$1,819,944
2024-12-13 2024-12-13 PrS Proposed sale
77,787
375.03
US$348,329
77,787 375.03 US$348,329